Q3 Earnings Forecast for INSP Issued By Leerink Partnrs

Key Points

• Leerink Partners lowered their Q3 2025 EPS estimate for Inspire Medical Systems from $0.72 to (0.21), while the consensus estimate for the full-year earnings is $2.16.
• Analysts have varied opinions on the stock, with price targets ranging from $150.00 to $236.00, and a consensus rating of "Moderate Buy."
• Inspire Medical Systems reported $0.45 EPS for the last quarter, exceeding estimates, and showed 10.8% revenue growth compared to the previous year.

Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) - Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Inspire Medical Systems in a report released on Tuesday, August 5th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings of ($0.21) per share for the quarter, down from their prior forecast of $0.72. The consensus estimate for Inspire Medical Systems' current full-year earnings is $2.16 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems' Q4 2025 earnings at $0.71 EPS, FY2025 earnings at $1.06 EPS, FY2026 earnings at $2.70 EPS, FY2027 earnings at $3.72 EPS and FY2028 earnings at $5.07 EPS.

A number of other research analysts have also recently issued reports on the stock. Robert W. Baird boosted their price objective on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a report on Tuesday, May 6th. UBS Group set a $230.00 price target on shares of Inspire Medical Systems and gave the company a "buy" rating in a report on Tuesday. Royal Bank Of Canada reduced their price target on shares of Inspire Medical Systems from $215.00 to $180.00 and set an "outperform" rating for the company in a report on Tuesday. Lake Street Capital set a $150.00 price objective on shares of Inspire Medical Systems and gave the stock a "buy" rating in a research report on Tuesday. Finally, KeyCorp lowered shares of Inspire Medical Systems from an "overweight" rating to a "sector weight" rating in a research report on Tuesday. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Inspire Medical Systems currently has a consensus rating of "Moderate Buy" and a consensus price target of $173.31.

Inspire Medical Systems Stock Down 10.7%

Shares of INSP stock opened at $78.54 on Thursday. Inspire Medical Systems has a 12-month low of $73.92 and a 12-month high of $225.00. The company has a market capitalization of $2.32 billion, a P/E ratio of 45.40, a P/E/G ratio of 6.76 and a beta of 1.22. The firm has a 50-day moving average price of $130.39 and a 200 day moving average price of $153.83.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.23. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The company had revenue of $217.09 million during the quarter, compared to the consensus estimate of $214.50 million. During the same quarter in the prior year, the firm earned $0.32 EPS. The company's revenue was up 10.8% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. SG Americas Securities LLC raised its holdings in Inspire Medical Systems by 14.7% during the first quarter. SG Americas Securities LLC now owns 4,055 shares of the company's stock worth $646,000 after buying an additional 521 shares during the last quarter. GAMMA Investing LLC boosted its position in Inspire Medical Systems by 253.7% during the first quarter. GAMMA Investing LLC now owns 573 shares of the company's stock worth $91,000 after purchasing an additional 411 shares during the period. New York State Teachers Retirement System lifted its holdings in shares of Inspire Medical Systems by 132.7% in the first quarter. New York State Teachers Retirement System now owns 21,390 shares of the company's stock worth $3,407,000 after buying an additional 12,196 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of Inspire Medical Systems by 1.7% in the first quarter. Bessemer Group Inc. now owns 7,183 shares of the company's stock worth $1,145,000 after buying an additional 123 shares in the last quarter. Finally, Parallel Advisors LLC raised its stake in Inspire Medical Systems by 356.5% in the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock valued at $33,000 after purchasing an additional 164 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.